<p>CryoPort（纳斯达克代码：CYRX - 获取免费报告）在周三发布的报告中，Needham &amp; Company LLC 将其目标股价从 12.00 美元上调至 13.00 美元，Benzinga 报道。该公司目前对该股票给予 “买入” 评级。Needham &amp; Company LLC 的目标股价指向该公司当前价格的潜在上涨幅度为 53.12%。</p>
<p>其他股票研究分析师也对该股票发布了研究报告。瑞银集团将 CryoPort 的目标股价从 11.00 美元上调至 12.50 美元，并在 11 月 5 日的报告中给予该股票 “买入” 评级。Weiss Ratings 在 12 月 29 日的研究报告中重申了对 CryoPort 的 “卖出（d+）” 评级。八位研究分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat 的数据，该股票的共识评级为 “适度买入”，平均目标股价为 12.94 美元。</p>
<p><strong>获取我们关于 CYRX 的最新报告</strong></p>
<h2>CryoPort 股价上涨 3.4%</h2>
<p>CryoPort 股票在周三开盘价为 8.49 美元。CryoPort 的一年低点为 4.58 美元，一年高点为 11.45 美元。该公司的 50 日移动平均价格为 9.51 美元，200 日移动平均价格为 9.41 美元。公司的债务与股本比率为 0.40，流动比率为 15.77，速动比率为 15.01。该股票的市值为 4.2509 亿美元，市盈率为 7.26，贝塔值为 1.69。</p>
<p>CryoPort（纳斯达克代码：CYRX - 获取免费报告）最后一次发布财报是在 3 月 3 日，报告显示该公司每股收益（EPS）为（0.27）美元，低于共识预期的（0.19）美元，差额为（0.08）美元。该公司在该季度的收入为 4545 万美元，而共识预期为 4292 万美元。CryoPort 的股本回报率为负 11.07%，净利润率为 35.57%。平均而言，股票分析师预测 CryoPort 在当前财政年度将发布 -0.99 的每股收益。</p>
<h2>CryoPort 的内部交易</h2>
<p>在相关消息中，董事 Ramkumar Mandalam 于 12 月 10 日星期三出售了 11,570 股该股票。该股票的平均售价为 9.99 美元，总价值为 115,584.30 美元。交易完成后，该董事直接持有该公司 80,758 股股票，价值约为 806,772.42 美元。这代表了他们持有的股票减少了 12.53%。该出售在与 SEC 的法律文件中披露，可以通过此链接访问。内部人士持有该公司 10.10% 的股票。</p>
<h2>机构投资者对 CryoPort 的看法</h2>
<p>几家机构投资者和对冲基金最近修改了对 CYRX 的持股。Assenagon Asset Management S.A. 在第三季度将其在 CryoPort 的持股增加了 37.4%。Assenagon Asset Management S.A. 现在拥有 1,498,774 股该公司的股票，价值 1,420.8 万美元，此前在该期间内购买了额外的 408,263 股。SG Americas Securities LLC 在第三季度将其在 CryoPort 的持股增加了 663.2%。SG Americas Securities LLC 现在拥有 127,280 股该公司的股票，价值 120.7 万美元，此前在上个季度购买了额外的 110,602 股。Y Intercept Hong Kong Ltd 在第二季度购买了 CryoPort 的新股份，价值约为 29.2 万美元。Bullseye Asset Management LLC 在第二季度将其在 CryoPort 的持股增加了 23.0%。Bullseye Asset Management LLC 现在拥有 260,168 股该公司的股票，价值 194.1 万美元，此前在上个季度获得了额外的 48,605 股。最后，Thematics Asset Management 在第二季度将其在 CryoPort 的持股增加了 12.8%。Thematics Asset Management 现在拥有 1,914,885 股该公司的股票，价值 1,428.5 万美元，此前在上个季度获得了额外的 216,937 股。对冲基金和其他机构投资者持有该公司 92.90% 的股票。</p>
<h2>CryoPort 公司简介</h2>
<p>（获取免费报告）</p>
<p>CryoPort, Inc（纳斯达克代码：CYRX）是生命科学行业温控物流解决方案的全球提供商。该公司专注于关键生物材料的低温运输，支持细胞和基因疗法、生物制品、疫苗和生殖医学的开发、临床测试和商业化。通过提供端到端的供应链管理，CryoPort 帮助确保温度敏感产品从起点到目的地的完整性和可行性。</p>
<p>CryoPort 的产品组合包括专有的低温干货运输工具、先进的主动和被动热包装以及实时数据监测平台。</p>
<h2>另见</h2>
<ul>
<li>五只我们更看好的股票，胜过 CryoPort</li>
<li>新发现的富铜 “克拉肯” 区</li>
<li>埃隆警告 “美国破产”。特朗普的计划在此。</li>
<li>美国的 1776 再次发生</li>
<li>你可能想更换财务顾问的 3 个迹象</li>
<li>白银的挤压正在收紧 - 机会正在形成</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1lSWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1lSWA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 CryoPort 吗？</h2>
<p>在你考虑 CryoPort 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 CryoPort 并不在名单上。</p>
<p>虽然 CryoPort 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

CYRX

<p>Needham & Company LLC 将 CryoPort (NASDAQ:CYRX) 的目标股价从 12.00 美元上调至 13.00 美元，维持 “买入” 评级。这表明与当前价格相比，潜在上涨幅度为 53.12%。包括瑞银集团在内的其他分析师也给予了积极评级。CryoPort 的股票开盘价为 8.49 美元，市值为 4.2509 亿美元。该公司报告的收入为 4545 万美元，但未达到每股收益预期。机构投资者持有 92.90% 的股份，显示出对该公司的强烈兴趣</p>

<p>CryoPort (NASDAQ:CYRX - Get Free Report) had its price target raised by stock analysts at Needham &amp; Company LLC from $12.00 to $13.00 in a report released on Wednesday,Benzinga reports. The firm currently has a &#34;buy&#34; rating on the stock. Needham &amp; Company LLC's price target points to a potential upside of 53.12% from the company's current price.</p>
<div class="lb-trans"><p>CryoPort（纳斯达克代码：CYRX - 获取免费报告）在周三发布的报告中，Needham &amp; Company LLC 将其目标股价从 12.00 美元上调至 13.00 美元，Benzinga 报道。该公司目前对该股票给予 “买入” 评级。Needham &amp; Company LLC 的目标股价指向该公司当前价格的潜在上涨幅度为 53.12%。</p>
</div><p>Other equities research analysts have also issued research reports about the stock. UBS Group raised their target price on shares of CryoPort from $11.00 to $12.50 and gave the stock a &#34;buy&#34; rating in a report on Wednesday, November 5th. Weiss Ratings reaffirmed a &#34;sell (d+)&#34; rating on shares of CryoPort in a research report on Monday, December 29th. Eight research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $12.94.</p>
<div class="lb-trans"><p>其他股票研究分析师也对该股票发布了研究报告。瑞银集团将 CryoPort 的目标股价从 11.00 美元上调至 12.50 美元，并在 11 月 5 日的报告中给予该股票 “买入” 评级。Weiss Ratings 在 12 月 29 日的研究报告中重申了对 CryoPort 的 “卖出（d+）” 评级。八位研究分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat 的数据，该股票的共识评级为 “适度买入”，平均目标股价为 12.94 美元。</p>
</div><p><strong>Get Our Latest Report on CYRX</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 CYRX 的最新报告</strong></p>
</div><h2>CryoPort Trading Up 3.4%</h2>
<div class="lb-trans"><h2>CryoPort 股价上涨 3.4%</h2>
</div><p>CryoPort stock opened at $8.49 on Wednesday. CryoPort has a 1 year low of $4.58 and a 1 year high of $11.45. The firm's 50 day moving average price is $9.51 and its 200-day moving average price is $9.41. The company has a debt-to-equity ratio of 0.40, a current ratio of 15.77 and a quick ratio of 15.01. The stock has a market cap of $425.09 million, a P/E ratio of 7.26 and a beta of 1.69.</p>
<div class="lb-trans"><p>CryoPort 股票在周三开盘价为 8.49 美元。CryoPort 的一年低点为 4.58 美元，一年高点为 11.45 美元。该公司的 50 日移动平均价格为 9.51 美元，200 日移动平均价格为 9.41 美元。公司的债务与股本比率为 0.40，流动比率为 15.77，速动比率为 15.01。该股票的市值为 4.2509 亿美元，市盈率为 7.26，贝塔值为 1.69。</p>
</div><p>CryoPort (NASDAQ:CYRX - Get Free Report) last issued its earnings results on Tuesday, March 3rd. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by ($0.08). The firm had revenue of $45.45 million during the quarter, compared to the consensus estimate of $42.92 million. CryoPort had a negative return on equity of 11.07% and a net margin of 35.57%. On average, equities analysts predict that CryoPort will post -0.99 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>CryoPort（纳斯达克代码：CYRX - 获取免费报告）最后一次发布财报是在 3 月 3 日，报告显示该公司每股收益（EPS）为（0.27）美元，低于共识预期的（0.19）美元，差额为（0.08）美元。该公司在该季度的收入为 4545 万美元，而共识预期为 4292 万美元。CryoPort 的股本回报率为负 11.07%，净利润率为 35.57%。平均而言，股票分析师预测 CryoPort 在当前财政年度将发布 -0.99 的每股收益。</p>
</div><h2>Insider Transactions at CryoPort</h2>
<div class="lb-trans"><h2>CryoPort 的内部交易</h2>
</div><p>In related news, Director Ramkumar Mandalam sold 11,570 shares of the stock in a transaction that occurred on Wednesday, December 10th. The stock was sold at an average price of $9.99, for a total value of $115,584.30. Following the completion of the transaction, the director directly owned 80,758 shares in the company, valued at approximately $806,772.42. This represents a 12.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 10.10% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，董事 Ramkumar Mandalam 于 12 月 10 日星期三出售了 11,570 股该股票。该股票的平均售价为 9.99 美元，总价值为 115,584.30 美元。交易完成后，该董事直接持有该公司 80,758 股股票，价值约为 806,772.42 美元。这代表了他们持有的股票减少了 12.53%。该出售在与 SEC 的法律文件中披露，可以通过此链接访问。内部人士持有该公司 10.10% 的股票。</p>
</div><h2>Institutional Investors Weigh In On CryoPort</h2>
<div class="lb-trans"><h2>机构投资者对 CryoPort 的看法</h2>
</div><p>Several institutional investors and hedge funds have recently modified their holdings of CYRX. Assenagon Asset Management S.A. increased its holdings in CryoPort by 37.4% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,498,774 shares of the company's stock worth $14,208,000 after purchasing an additional 408,263 shares during the period. SG Americas Securities LLC grew its position in shares of CryoPort by 663.2% during the third quarter. SG Americas Securities LLC now owns 127,280 shares of the company's stock worth $1,207,000 after buying an additional 110,602 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new stake in shares of CryoPort during the second quarter worth approximately $292,000. Bullseye Asset Management LLC lifted its stake in CryoPort by 23.0% in the second quarter. Bullseye Asset Management LLC now owns 260,168 shares of the company's stock worth $1,941,000 after acquiring an additional 48,605 shares during the last quarter. Finally, Thematics Asset Management lifted its stake in CryoPort by 12.8% in the second quarter. Thematics Asset Management now owns 1,914,885 shares of the company's stock worth $14,285,000 after acquiring an additional 216,937 shares during the last quarter. Hedge funds and other institutional investors own 92.90% of the company's stock.</p>
<div class="lb-trans"><p>几家机构投资者和对冲基金最近修改了对 CYRX 的持股。Assenagon Asset Management S.A. 在第三季度将其在 CryoPort 的持股增加了 37.4%。Assenagon Asset Management S.A. 现在拥有 1,498,774 股该公司的股票，价值 1,420.8 万美元，此前在该期间内购买了额外的 408,263 股。SG Americas Securities LLC 在第三季度将其在 CryoPort 的持股增加了 663.2%。SG Americas Securities LLC 现在拥有 127,280 股该公司的股票，价值 120.7 万美元，此前在上个季度购买了额外的 110,602 股。Y Intercept Hong Kong Ltd 在第二季度购买了 CryoPort 的新股份，价值约为 29.2 万美元。Bullseye Asset Management LLC 在第二季度将其在 CryoPort 的持股增加了 23.0%。Bullseye Asset Management LLC 现在拥有 260,168 股该公司的股票，价值 194.1 万美元，此前在上个季度获得了额外的 48,605 股。最后，Thematics Asset Management 在第二季度将其在 CryoPort 的持股增加了 12.8%。Thematics Asset Management 现在拥有 1,914,885 股该公司的股票，价值 1,428.5 万美元，此前在上个季度获得了额外的 216,937 股。对冲基金和其他机构投资者持有该公司 92.90% 的股票。</p>
</div><h2>CryoPort Company Profile</h2>
<div class="lb-trans"><h2>CryoPort 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>CryoPort, Inc NASDAQ: CYRX is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.</p>
<div class="lb-trans"><p>CryoPort, Inc（纳斯达克代码：CYRX）是生命科学行业温控物流解决方案的全球提供商。该公司专注于关键生物材料的低温运输，支持细胞和基因疗法、生物制品、疫苗和生殖医学的开发、临床测试和商业化。通过提供端到端的供应链管理，CryoPort 帮助确保温度敏感产品从起点到目的地的完整性和可行性。</p>
</div><p>CryoPort's product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.</p>
<div class="lb-trans"><p>CryoPort 的产品组合包括专有的低温干货运输工具、先进的主动和被动热包装以及实时数据监测平台。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than CryoPort</li>
<li>New Copper-Rich “Kraken” Zone Discovered</li>
<li>Elon Warns “America Is Broke”. Trump’s Plan Inside.</li>
<li>America’s 1776 happening again</li>
<li>3 Signs You May Want to Switch Financial Advisors</li>
<li>Silver's squeeze is tightening - opportunity forming</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 CryoPort</li>
<li>新发现的富铜 “克拉肯” 区</li>
<li>埃隆警告 “美国破产”。特朗普的计划在此。</li>
<li>美国的 1776 再次发生</li>
<li>你可能想更换财务顾问的 3 个迹象</li>
<li>白银的挤压正在收紧 - 机会正在形成</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1lSWA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=CYRX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CryoPort Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 CryoPort 吗？</h2>
</div><p>Before you consider CryoPort, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 CryoPort 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CryoPort wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 CryoPort 并不在名单上。</p>
</div><p>While CryoPort currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CryoPort 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Needham & Company LLC 预测 CryoPort（NASDAQ:CYRX）股票将迎来强劲的价格上涨